We are live on ! Find out more
CC

Claybrook Capital Portfolio holdings

AUM $175M
1-Year Est. Return 10.74%
This Fund
S&P 500
This Quarter Est. Return
+7.54%
1 Year Est. Return
+10.74%
3 Year Est. Return
+7.15%
5 Year Est. Return
+9.06%
10 Year Est. Return
AUM
$307M
AUM Growth
+$135M
Cap. Flow
+$126M
Cap. Flow %
41.01%
Top 10 Hldgs %
32.64%
Holding
247
New
137
Increased
18
Reduced
8
Closed
84

Sector Composition

Rank Sector Weight
1 Technology 20.91%
2 Healthcare 13.77%
3 Consumer Staples 11.35%
4 Communication Services 9.92%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
101
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$580K 0.19%
1,356
-34,670
-96% -$14.5M
SYY icon
102
Sysco
SYY
$40.8B
$575K 0.19%
+7,394
New +$597K
ODFL icon
103
Old Dominion Freight Line
ODFL
$44.1B
$517K 0.17%
+4,074
New +$522K
VO icon
104
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$512K 0.17%
8,628
+4,228
+96% +$245K
SCHM icon
105
Schwab US Mid-Cap ETF
SCHM
$14.5B
$511K 0.17%
+19,602
New +$506K
MDT icon
106
Medtronic
MDT
$109B
$502K 0.16%
+4,042
New +$508K
CFG icon
107
Citizens Financial Group
CFG
$30.3B
$501K 0.16%
+10,921
New +$515K
AVGO icon
108
Broadcom
AVGO
$1.85T
$498K 0.16%
+10,450
New +$484K
TFC icon
109
Truist Financial
TFC
$63.3B
$498K 0.16%
+8,979
New +$527K
MTB icon
110
M&T Bank
MTB
$35.7B
$495K 0.16%
+3,408
New +$532K
REGN icon
111
Regeneron Pharmaceuticals
REGN
$78.5B
$481K 0.16%
+861
New +$436K
VRTX icon
112
Vertex Pharmaceuticals
VRTX
$121B
$471K 0.15%
+2,335
New +$488K
LITE icon
113
Lumentum
LITE
$55.5B
$469K 0.15%
+5,715
New +$480K
LLY icon
114
Eli Lilly
LLY
$1.02T
$445K 0.15%
+1,940
New +$390K
MO icon
115
Altria Group
MO
$114B
$437K 0.14%
9,167
-28,428
-76% -$1.4M
BA icon
116
Boeing
BA
$171B
$408K 0.13%
1,705
-11,345
-87% -$2.74M
BRK.B icon
117
Berkshire Hathaway Class B
BRK.B
$1.1T
$404K 0.13%
1,454
-11,866
-89% -$3.32M
AMD icon
118
Advanced Micro Devices
AMD
$776B
$401K 0.13%
+4,266
New +$345K
KO icon
119
Coca-Cola
KO
$377B
$400K 0.13%
7,388
-9,212
-55% -$501K
EW icon
120
Edwards Lifesciences
EW
$49.6B
$398K 0.13%
+3,846
New +$363K
RSP icon
121
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$386K 0.13%
+2,560
New +$381K
IWM icon
122
iShares Russell 2000 ETF
IWM
$79.8B
$378K 0.12%
+1,646
New +$370K
SCHB icon
123
Schwab US Broad Market ETF
SCHB
$43.2B
$372K 0.12%
+21,426
New +$363K
BABA icon
124
Alibaba
BABA
$293B
$370K 0.12%
+1,633
New +$363K
DFS
125
DELISTED
Discover Financial Services
DFS
$356K 0.12%
+3,007
New +$340K

Similar funds

Claybrook Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Claybrook Capital held 247 positions worth $307M, up 78% from $172M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Claybrook Capital deployed $126M of net new capital in Q2 2021, opening 137 new positions and adding to 18 existing holdings. Its largest new stake was Alphabet (Google) Class A: 95,460 shares worth $11.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 5.6% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $14.5M trimmed.

  • Claybrook Capital's largest Q2 2021 buy was Alphabet (Google) Class A: 95,460 shares worth $11.7M.
  • Claybrook Capital added most to Apple in Q2 2021, an estimated $18.1M increase.
  • Claybrook Capital's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $14.5M.
  • Claybrook Capital fully exited Nuveen New York AMT-Free Quality Municipal Income Fund in Q2 2021, selling an estimated $10.8M.
  • Claybrook Capital's ten largest holdings make up 33% of its $307M portfolio in Q2 2021.
  • Claybrook Capital opened 137 new positions and closed 84 in Q2 2021.
  • Claybrook Capital's portfolio value rose 78% quarter-over-quarter to $307M.

Based on Claybrook Capital's 13F filing for Q2 2021, filed 26 Jul 2021.